A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease
Wenning GK, O'Connell MT, Patsalos PN, Quinn NP. A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease. Mov Disord 1995; 10:664-667.
Parkinsonism induced by atypical neuroleptics in a patient with severe iron deficiency
Yoshida T, Suzuki G, Nibuya M, Sano SY, Nomura S. Parkinsonism induced by atypical neuroleptics in a patient with severe iron deficiency. Nihon Shinkei Seishin Yakurigaku Zasshi 2004;24:29-31.
A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease
Tyne HL, Parsons J, Sinnott A, Fox SH, Fletcher NA, Steiger MJ. A 10 year retrospective audit of long-term apomorphine use in Parkinson's disease. J Neurol 2004;251:1370-1374.
Revisiting transfusion practices in critically ill patients
Canadian Critical Care Trials Group
Hebert PC, Fergusson DA, Stather D, et al., Canadian Critical Care Trials Group. Revisiting transfusion practices in critically ill patients. Crit Care Med 2005;33:7-12.